Takeda Divesting Select OTC and Non-core Assets of takeda to Acino
Posted on25 Oct 2019
Tagsdisinvestment in pharma business, divestiment in pharma, Divestment in pharma, Takeda, Takeda acquires shire
Comments0
Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select over-the-counter (OTC) and prescription... Read More
Dr. Reddy’s Laboratories closes the acquisition of Habitrol® Brand from Novartis
Dr. Reddy’s Laboratories has announced that it has closed the acquisition of Habitrol® brand (an over-the-counter nicotine replacement therapy transdermal patch) from... Read More